Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Halozyme Therapeutics Company Profile (NASDAQ:HALO)

Consensus Ratings for Halozyme Therapeutics (NASDAQ:HALO) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $11.13 (16.86% upside)

Analysts' Ratings History for Halozyme Therapeutics (NASDAQ:HALO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/11/2014JPMorgan Chase & Co.Initiated CoverageOverweight$13.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2014Citigroup Inc.Initiated CoverageBuy$12.00ViewTweet This Rating  Share This Rating on StockTwits
4/4/2014BMO Capital MarketsReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
1/27/2014Jefferies GroupBoost Price Target$4.00 -> $4.50ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014BarclaysReiterated RatingEqual Weight$12.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013BMO Capital MarketsBoost Price Target$13.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013BarclaysBoost Price TargetEqual Weight$8.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
8/2/2013Jefferies GroupLower Price TargetUnderperform$4.50 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
8/2/2013BarclaysDowngradeOverweight -> Equal Weight$9.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
7/1/2013Jefferies GroupBoost Price Target$4.00 -> $4.50ViewTweet This Rating  Share This Rating on StockTwits
5/16/2013JMP SecuritiesBoost Price TargetMarket Outperform$10.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
5/14/2013Piper JaffrayInitiated CoverageOverweight -> Overweight$10.00ViewTweet This Rating  Share This Rating on StockTwits
2/28/2013WedbushLower Price TargetNeutral$13.00 -> $6.00ViewTweet This Rating  Share This Rating on StockTwits
2/1/2013BarclaysReiterated RatingOverweight$9.00ViewTweet This Rating  Share This Rating on StockTwits
2/1/2013BMO Capital MarketsLower Price TargetOutperform$12.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2013WedbushDowngradeOutperform -> NeutralViewTweet This Rating  Share This Rating on StockTwits
1/30/2013Jefferies GroupReiterated RatingUnderperform$4.00ViewTweet This Rating  Share This Rating on StockTwits
1/14/2013BMO Capital MarketsUpgradeMarket Perform -> Outperform$4.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
10/8/2012WedbushBoost Price TargetOutperform -> Outperform$13.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
9/24/2012BarclaysBoost Price TargetOverweight$8.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
8/16/2012BarclaysReiterated RatingOverweightViewTweet This Rating  Share This Rating on StockTwits
8/2/2012Jefferies GroupDowngradeHold -> UnderperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2012 forward)